This inventor holds 2 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Xiaolian He - Innovator in Biotechnology
Xiaolian He is a prominent inventor based in Lianyungang, China. She is currently associated with Jiangsu Kanion Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her contributions to the field of biotechnology are noteworthy.
Latest Patent Applications:
Xiaolian He has been involved in several significant patent applications. One of her latest applications is titled "Recombinant Newcastle Disease Virus and Preparation Method Therefor, Recombinant Plasmid, and Use Thereof." This application describes a recombinant Newcastle disease virus obtained by replacing an F protein of a Newcastle disease virus lasota with an F protein encoded by a specific DNA sequence. The recombinant Newcastle disease virus is noted for its safety and effectiveness in inhibiting tumor cells and promoting tumor cell apoptosis. Another application under the same title details a recombinant chimeric virus that has good safety and is capable of effectively treating tumors by promoting tumor cell apoptosis.
Conclusion:
Xiaolian He is making strides in the biotechnology sector with her innovative research and applications. Her work holds promise for advancements in cancer treatment and viral research.